🇺🇸 FDA
Patent

US 9617268

Compounds for treating spinal muscular atrophy

granted A61PA61P21/00A61P21/02

Quick answer

US patent 9617268 (Compounds for treating spinal muscular atrophy) held by PTC THERAPEUTICS, INC. expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P21/00, A61P21/02, A61P25/00